Literature DB >> 32806026

Tracing the In Vivo Fate of Nanoparticles with a "Non-Self" Biological Identity.

Hossein Mohammad-Beigi1, Carsten Scavenius2, Pia Bomholt Jensen1, Kasper Kjaer-Sorensen2, Claus Oxvig2, Thomas Boesen1, Jan J Enghild2, Duncan S Sutherland1, Yuya Hayashi2.   

Abstract

Nanoparticles can acquire a biomolecular corona with a species-specific biological identity. However, "non-self" incompatibility of recipient biological systems is often not considered, for example, when rodents are used as a model organism for preclinical studies of biomolecule-inspired nanomedicines. Using zebrafish embryos as an emerging model for nanobioimaging, here we unravel the in vivo fate of intravenously injected 70 nm SiO2 nanoparticles with a protein corona preformed from fetal bovine serum (FBS), representing a non-self biological identity. Strikingly rapid sequestration and endolysosomal acidification of nanoparticles with the preformed FBS corona were observed in scavenger endothelial cells within minutes after injection. This led to loss of blood vessel integrity and to inflammatory activation of macrophages over the course of several hours. As unmodified nanoparticles or the equivalent dose of FBS proteins alone failed to induce the observed pathophysiology, this signifies how the corona enriched with a differential repertoire of proteins can determine the fate of the nanoparticles in vivo. Our findings thus reveal the adverse outcome triggered by incompatible protein coronas and indicate a potential pitfall in the use of mismatched species combinations during nanomedicine development.

Entities:  

Keywords:  intravital confocal microscopy; macrophage polarization; nanoparticles; protein corona; transmission electron microscopy (TEM); uptake kinetics; zebrafish embryos

Mesh:

Substances:

Year:  2020        PMID: 32806026     DOI: 10.1021/acsnano.0c05178

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  2 in total

1.  Ultrasmall Coordination Polymers for Alleviating ROS-Mediated Inflammatory and Realizing Neuroprotection against Parkinson's Disease.

Authors:  Guowang Cheng; Xueliang Liu; Yujing Liu; Yao Liu; Rui Ma; Jingshan Luo; Xinyi Zhou; Zhenfeng Wu; Zhuang Liu; Tongkai Chen; Yu Yang
Journal:  Research (Wash D C)       Date:  2022-07-18

2.  Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease.

Authors:  Qun Wang; Rui Ma; Piaoxue Liu; Guowang Cheng; Qi Yang; Xiaojia Chen; Zhenfeng Wu; Dongsheng Yuan; Tongkai Chen
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.